Literature DB >> 35303530

Clonal expansion and markers of directed mutation of IGHV4-34 B cells in plasmablasts during Kawasaki disease.

Arthur J Chang1, Sarah Baron1, Jonathon Hoffman1, Mark D Hicar2.   

Abstract

Kawasaki disease (KD) is the leading cause of acquired heart disease in children. The cause remains unknown; however, epidemiologic and demographic data support a single preceding infectious agent may lead to KD. A variety of pathophysiologic responses have been proposed, including direct invasion of the coronary arteries, a superantigen response, and a post-infectious autoimmune phenomenon. A role for B cell responses during KD are supported by numerous findings including B cell specific markers identified in genome wide association studies. We have recently published data showing children with KD have similar plasmablast (PB) responses to children with infections. Since during other infections, cells expressing antibodies against the preceding infection are enriched in PBs, we sought to explore the specific antibodies encoded by PBs during KD. In one child we see a massive expansion in IGHV4-34 utilizing antibodies, which has been associated with autoimmunity in the past. We further explored this expansion of IGHV4-34 utilization during the peripheral PB rise with next generation sequencing (NGS) analysis and utilizing newer techniques of chromium chip single cell separation (10x Genomics®). We also utilized peptide array screening to attempt to identify an antigen to the most prolific clones.
Copyright © 2022 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antibody; Autoantibodies; Directed mutations; Kawasaki disease

Mesh:

Substances:

Year:  2022        PMID: 35303530      PMCID: PMC9166636          DOI: 10.1016/j.molimm.2022.03.011

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.174


  61 in total

1.  Surface and cytoplasmic immunoglobulin expression in circulating B-lymphocytes in acute Kawasaki disease.

Authors:  D Shingadia; M O'Gorman; A H Rowley; S T Shulman
Journal:  Pediatr Res       Date:  2001-10       Impact factor: 3.756

2.  Change-O: a toolkit for analyzing large-scale B cell immunoglobulin repertoire sequencing data.

Authors:  Namita T Gupta; Jason A Vander Heiden; Mohamed Uduman; Daniel Gadala-Maria; Gur Yaari; Steven H Kleinstein
Journal:  Bioinformatics       Date:  2015-06-10       Impact factor: 6.937

3.  Human monoclonal antibodies against blood group antigens preferentially express a VH4-21 variable region gene-associated epitope.

Authors:  K M Thompson; J Sutherland; G Barden; M D Melamed; I Randen; J B Natvig; V Pascual; J D Capra; F K Stevenson
Journal:  Scand J Immunol       Date:  1991-10       Impact factor: 3.487

4.  Plasmablast frequency and trafficking receptor expression are altered in pediatric ulcerative colitis.

Authors:  Nicole J Tarlton; Caroline M Green; Nicole H Lazarus; Lusijah Rott; Anthony P Wong; Oren N Abramson; Martina Bremer; Eugene C Butcher; Tzvia Abramson
Journal:  Inflamm Bowel Dis       Date:  2012-04-05       Impact factor: 5.325

5.  The B cell superantigen-like interaction of intravenous immunoglobin (IVIG) with Fab fragments of V(H) 3-23 and 3-30/3-30.5 germline gene origin cloned from a patient with Kawasaki disease is enhanced after IVIG therapy.

Authors:  S Leucht; M M Uttenreuther-Fischer; G Gaedicke; P Fischer
Journal:  Clin Immunol       Date:  2001-04       Impact factor: 3.969

6.  Expansion of CD27high plasmablasts in transverse myelitis patients that utilize VH4 and JH6 genes and undergo extensive somatic hypermutation.

Authors:  A J Ligocki; W H Rounds; E M Cameron; C T Harp; E M Frohman; A M Courtney; S Vernino; L G Cowell; B Greenberg; N L Monson
Journal:  Genes Immun       Date:  2013-04-18       Impact factor: 2.676

7.  Rapid cloning of high-affinity human monoclonal antibodies against influenza virus.

Authors:  Jens Wrammert; Kenneth Smith; Joe Miller; William A Langley; Kenneth Kokko; Christian Larsen; Nai-Ying Zheng; Israel Mays; Lori Garman; Christina Helms; Judith James; Gillian M Air; J Donald Capra; Rafi Ahmed; Patrick C Wilson
Journal:  Nature       Date:  2008-04-30       Impact factor: 49.962

8.  Structural analysis of VH4-21 encoded human IgM allo- and autoantibodies against red blood cells.

Authors:  M Børretzen; C Chapman; F K Stevenson; J B Natvig; K M Thompson
Journal:  Scand J Immunol       Date:  1995-07       Impact factor: 3.487

9.  Lupus IgG VH4.34 antibodies bind to a 220-kDa glycoform of CD45/B220 on the surface of human B lymphocytes.

Authors:  Amedeo J Cappione; Aimee E Pugh-Bernard; Jennifer H Anolik; Iñaki Sanz
Journal:  J Immunol       Date:  2004-04-01       Impact factor: 5.422

10.  Immunoglobulin V(H) chain gene analysis of peripheral blood IgM-producing B cells in patients with Kawasaki disease.

Authors:  Hyun Hee Lee; In Ho Park; Jeon-Soo Shin; Jun Soo Shin; Dong Soo Kim
Journal:  Yonsei Med J       Date:  2009-08-19       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.